InvestorsHub Logo
Followers 50
Posts 9227
Boards Moderated 1
Alias Born 10/25/2007

Re: Monksdream post# 11

Tuesday, 11/14/2023 9:16:54 AM

Tuesday, November 14, 2023 9:16:54 AM

Post# of 23
Cash runway extended through multiple data readouts and into Q1 of calendar 2025

MDNA11 is generally well tolerated and continues to demonstrate encouraging single-agent activity from Phase 1 portion of the ABILITY-1 Study including 100% and 70% reduction of target lesions in pancreatic and melanoma cancer patients, respectively

https://ir.medicenna.com/news-releases/news-release-details/medicenna-therapeutics-reports-second-quarter-fiscal-2024
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MDNAF News